Literature DB >> 19740485

Neuromyelitis optica: effect of gender.

Dean M Wingerchuk1.   

Abstract

Neuromyelitis optica is a distinct CNS demyelinating disease associated with the autoantibody NMO-IgG, which targets the water channel aquaporin-4. Neuromyelitis optica may be distinguished from typical multiple sclerosis on the basis of key clinical and neuroimaging characteristics in addition to detection of NMO-IgG. The disease has an even stronger female predilection than does multiple sclerosis, with a reasonably consistent female to male gender ratio of >3:1 reported from samples of diverse racial and regional populations worldwide. The gender distribution appears to be similar in both childhood-onset and adult-onset cases. Female gender is associated with a relapsing course and familial disease, but the influence of gender on disease severity and treatment response are not clear. Population-based epidemiological and genetic studies, with case ascertainment aided by the high specificity of NMO-IgG and consistent disease definitions, are needed to better define and understand gender effects in neuromyelitis optica.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740485     DOI: 10.1016/j.jns.2009.08.045

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  31 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Effects of age and sex on aquaporin-4 autoimmunity.

Authors:  Amy M L Quek; Andrew McKeon; Vanda A Lennon; Jayawant N Mandrekar; Raffaele Iorio; Yujuan Jiao; Chiara Costanzi; Brian G Weinshenker; Dean M Wingerchuk; Claudia F Lucchinetti; Elizabeth A Shuster; Sean J Pittock
Journal:  Arch Neurol       Date:  2012-08

Review 3.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

4.  The incidence and prevalence of neuromyelitis optica: a systematic review.

Authors:  Ruth Ann Marrie; Caroline Gryba
Journal:  Int J MS Care       Date:  2013

5.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

6.  Neuromyelitis optica and pregnancy.

Authors:  Yára Dadalti Fragoso; Tarso Adoni; Denis Bernardi Bichuetti; Joseph Bruno Bidin Brooks; Maria Lucia Brito Ferreira; Enedina Maria Lobato Oliveira; Celso Luis Silva Oliveira; Sonia Beatriz Felix Ribeiro; Alex Eduardo Silva; Fabio Siquineli
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

Review 7.  Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.

Authors:  Nadja Borisow; Kerstin Hellwig; Friedemann Paul
Journal:  EPMA J       Date:  2018-08-10       Impact factor: 6.543

Review 8.  [Neuromyelitis optica spectrum disorder and pregnancy].

Authors:  N Borisow; K Hellwig; F Paul
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

9.  Male patients with neuromyelitis optica spectrum disorders: different clinical characteristics and worse steroid treatment response.

Authors:  Rui Li; Cong Li; Zhifeng Mao; Qiao Huang; Yaqing Shu; Yanyu Chang; Jingqi Wang; Yuge Wang; Wei Qiu
Journal:  Neurol Sci       Date:  2020-11-27       Impact factor: 3.307

Review 10.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.